ACITRETIN (AvKARE, Inc.)


Welcome to the PulseAid listing for the ACITRETIN drug offered from AvKARE, Inc.. This Retinoid [EPC],Retinoids [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: AvKARE, Inc.
NON-PROPRIETARY NAME: ACITRETIN
SUBSTANCE NAME: ACITRETIN
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Retinoid [EPC],Retinoids [Chemical/Ingredient]
ROUTE: ORAL
DOSAGE FORM: CAPSULE
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2017-10-11
END MARKETING DATE: 0000-00-00


ACITRETIN HUMAN PRESCRIPTION DRUG Details:

Item DescriptionACITRETIN from AvKARE, Inc.
LABELER NAME: AvKARE, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 10(mg/1)
START MARKETING DATE: 2017-10-11
END MARKETING DATE: 0000-00-00
PRODUCT ID: 42291-086_5c10be6d-9838-491d-8542-4c535e083d91
PRODUCT NDC: 42291-086
APPLICATION NUMBER: ANDA204633

Other ACITRETIN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Actavis Pharma, Inc.Acitretin
AvKARE, Inc.ACITRETIN
Impax GenericsAcitretin
Mylan Pharmaceuticals Inc.Acitretin
Prasco LaboratoriesACITRETIN
Sigmapharm Laboratories, LLCACITRETIN
Stiefel Laboratories IncSORIATANE
Teva Pharmaceuticals USA, Inc.Acitretin